Back to Atlas
BSemi-durableStandard research/education caution
CMP-0227
Experimental
P21 / P021
Nootropic / Neuroregenerative
Neuroplasticity and cognitive rescue positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- CNTF-derived neurotrophic signaling
- Primary market use
- Neurodegeneration
Pharmacology
- Molecular weight (Da)
- Varies by form
- Oral bioavailability
- Unknown
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Preclinical
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem/peptide research interest